How Does Type I Interferon Affect Skeletal Muscle Contractile Force? Insights Into Juvenile Dermatomyositis Using Engineered Tissue Model

Saturday, April 23, 2022

2:00 PM – 2:15 PM US MT

Location: Convention Center: Mile High Ballroom 1AB

CE: Enduring CME: 0.25

Publication Number: 1435.5

Lauren T. Covert, Duke University School of Medicine, Durham, NC, United States; Hailee Patel, Duke University, Durham, NC, United States; George A. Truskey, Duke University, Durham, NC, United States; Jeffrey A. Dvergsten, Duke University Medical Center, Hillsborough, NC, United States

Presenting Author(s)

Lauren T. Covert, MD
Pediatric Rheumatology Fellow
Duke Children's Hospital
Durham, North Carolina, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Lauren T. Covert, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Hailee Patel, Patel, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

George A. Truskey, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jeffrey A. Dvergsten, MD: ● Pfizer (Ended In the Past 24 Months) (Products/Services: Advisory Committee).